Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CASSAVA SCIENCES INC (PTIE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Quarterly results
Docs: "Cassava Sciences Reports Q2 2023 Financial Results and Operating Updates"
07/05/2023 8-K Quarterly results
05/08/2023 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits  Interactive Data
05/01/2023 8-K Quarterly results
05/01/2023 8-K Quarterly results
Docs: "Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates"
03/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
02/28/2023 8-K Quarterly results
Docs: "Cassava Sciences Reports Full-year 2022 Financial Results and Operating Updates"
01/24/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease"
12/22/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED BYLAWS OF CASSAVA SCIENCES, INC."
11/22/2022 8-K Quarterly results
11/07/2022 8-K Quarterly results
Docs: "Cassava Sciences Reports Third Quarter Financial Results for 2022 and Business Updates – $174.7 Million Cash and Cash Equivalents at September 30, 2022 – – Over 650 Patients Now Enrolled in Phase 3 Program - – New Clinical Data for Simufilam in Alzheimer’s Disease Expected –"
11/03/2022 8-K Quarterly results
10/27/2022 8-K Quarterly results
09/23/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
08/03/2022 8-K Quarterly results
Docs: "Cassava Sciences Reports Second Quarter Financial Results for 2022, Mid-year Corporate Update and Interim Analysis of Open-label Study"
05/09/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
04/26/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Cassava Sciences, Inc."
02/28/2022 8-K Quarterly results
Docs: "Cassava Sciences Reports Full-year 2021 Financial Results and Operating Updates"
01/06/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/10/2021 8-K Quarterly results
Docs: "Cassava Sciences Reports Third Quarter 2021 Financial Results"
08/03/2021 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Cassava Sciences, Inc. 2021 AAIC presentation",
"Cassava Sciences, Inc. July 29, 2021 Page 4 of 5",
"Cautionary Note Regarding Forward-Looking Statements: This news release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, relating to: the treatment or diagnosis of Alzheimer’s disease; the status of current and future clinical studies with simufilam, including the interpretation of interim analyses of open-label study results; plans to conduct additional interim analyses of an open-label study and the timing thereof; inherent limitations of the ADAS-Cog testing batteries; expectations regarding convergence of biomarker and cognition data, and treatment benefits of simufilam; our intention to initiate a Phase 3 clinical program with simufilam and the timing, enrollment, duration and..."
08/03/2021 8-K Quarterly results
06/21/2021 8-K Quarterly results
06/14/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
04/21/2021 8-K Quarterly results
03/23/2021 8-K Quarterly results
03/11/2021 8-K Quarterly results
02/12/2021 8-K Quarterly results
02/08/2021 8-K Quarterly results
01/06/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement, executed on January 1, 2021, by and between Cassava Sciences, Inc. and Dr. James Kupiec",
"Cassava Sciences, Inc. Page 3 of 3 Cassava Sciences Safe Harbor"
12/11/2020 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Amended and Restated By-Laws of Cassava Sciences, Inc."
11/13/2020 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement",
"Opinion of Morrison & Foerster LLP",
"Forward-Looking Statements",
"Forward Looking Statements"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy